EA
GILD icon

Emerald Acquisition’s Gilead Sciences GILD Stock Holding History

Emerald Acquisition’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$118M Sell
1,488,379
-60,622
-4% -$4.92M 0.23% 91
2016
Q2 		$129M Buy
+1,549,001
New +$137M 0.22% 97

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Emerald Acquisition's GILD Position: Q3 2016 in Review

Emerald Acquisition reduced its Gilead Sciences (GILD) stake by 3.9% in Q3 2016, selling an estimated $4.92M and leaving 1,488,379 shares worth $118M. The position accounts for 0.23% of the portfolio, ranked #91.

Emerald Acquisition first reported a position in GILD in Q2 2016 and has held it in 2 quarters since. The position peaked at $129M in Q2 2016. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Emerald Acquisition held 1,488,379 shares of Gilead Sciences worth $118M as of Q3 2016.
  • Emerald Acquisition sold 60,622 Gilead Sciences shares in Q3 2016, an estimated $4.92M.
  • Gilead Sciences made up 0.23% of Emerald Acquisition's portfolio in Q3 2016, its #91 holding.
  • Emerald Acquisition first reported a position in Gilead Sciences in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Gilead Sciences position peaked at $129M in Q2 2016.
  • 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.